Skip to main content

Table 1 Clinical parameters of MM patients

From: Inhibition of bromodomain and extra-terminal (BET) proteins increases NKG2D ligand MICA expression and sensitivity to NK cell-mediated cytotoxicity in multiple myeloma cells: role of cMYC-IRF4-miR-125b interplay

Patient

Sex/age

Clinical state

Monoclonal Ig

% PCs in BM

1

F/42

Onset

IgG-k

52

2

M/71

Relapse

IgG-L

29

3

M/52

Onset

IgA-k

30

4

M/73

Smoldering

IgG-L

22

5

F/73

Smoldering

IgA-L

34

6

M/50

Onset

IgG-L

60

7

F/68

Relapse

IgG-L

19

8

M/75

Relapse

Micro-k

90

9

M/58

Onset

IgG-k

60

10

F/46

Onset

IgG-L

67

11

M/75

Relapse

IgG-k

32

12

M/71

Relapse

IgG-k

52

13

F/78

Relapse

IgG-k

51

14

M/68

Relapse

IgG-k

44

15

M/75

Onset

IgG-L

24

16

F/54

Onset

IgG-L

34

17

F/61

Relapse

IgG-L

38

18

F/78

Onset

IgG-k

40

19

M/73

Smoldering

IgG-λ

13

20

M/71

Onset

IgG-k

60

  1. Patients were classified according to the status of disease. The percentage of plasma cells in the BM and monoclonal Ig is indicated